1-Tetrazolylpropan-2-ones as inhibitors of cytosolic phospholipase A2 and fatty acid amide hydrolase, in particular suitable for topical application
DE102012018789A1
New N-isopropylcarbamate compound is phospholipase A2 inhibitor, useful for prophylactic and/or therapeutic treatment of diseases e.g. inflammation, psoriasis, cerebral ischemia, Alzheimer's disease, chronic skin diseases and thrombosis
DE102012018115A1
New aryl-N-(arylalkyl) carbamate compounds, used to prepare pharmaceutical composition for prophylactic and/or therapeutic treatment of diseases including e.g. acute and chronic neurogenic pain, and neurological and psychiatric diseases
DE102012017516A1
New 1-aryloxy-3-pyrrol-1-yl-propan-2-one derivatives are cytosolic phospholipase A2 inhibitors, useful for prophylactic or therapeutic treatment of diseases caused by increased activity of phospholipase A2, preferably e.g. pain and fever
US2014035099A1
Integrated circuits with metal-insulator-metal (MIM) capacitors and methods for fabricating same
US2012030312A1
Transport of customer flexibility changes in a multi-tenant environment
US2011154253A1
Propagating business object extension fields from source to target
DE4325204A1
Acylpyrrolealcanoic acids and their derivatives as inhibitors of phospholipase A¶2¶
